Heart failure: Update on treatment and prognosis

American Journal of Critical Care

Volumn 10, Issue 4, 2001, Pages 285-293

  Futterman, Laurie G ^a   Lemberg, Louis ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; CASE REPORT; CONGESTIVE HEART FAILURE; EXERCISE; HEART ASSIST DEVICE; HEART VENTRICLE REMODELING; HUMAN; INTENSIVE CARE; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PROGNOSIS; SODIUM RESTRICTION;

ADRENERGIC BETA-ANTAGONISTS; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIET, SODIUM-RESTRICTED; DIURETICS; EXERCISE; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROGNOSIS; VENTRICULAR REMODELING;

EID: 0035408453     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2001.10.4.285     Document Type: Review

References (20)

1. Wilson JR, Schwartz JS, St John Salton M, et al: Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol. 1983;2:403-410.
2. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperation North Scandinavian Enalapril Survival Study. N Engl J Med. 1987;316:1429-1435.
3. Stevenson WG, Stevenson LW, Middlehauff HR, et al. Results of major trials influence therapy and survival for patients with advanced heart failure [abstract]. Circulation. 1994;90:380.
4. Katz AM, Silverman DI. Treatment of heart failure. Hosp Practice. December 2000;15:19-31.
5. Maisel AS. BNP levels predict outcomes in patients admitted for decompensated heart failure. Cardiol Rev Suppl. November 2000;17(11):5.
6. Albert N, Young JB. Heart failure disease management: a team approach. Cleveland Clin J Med. 2001;68:53-62.
7. Heckman G, McKelvie RS. Prevention of congestive heart failure and treatment of asymptomatic left ventricular systolic dysfunction in the elderly. Clin Geriatr. 2000;8(10):76-86.
8. Zornoff LAM, Solomon SD. Bradykinin and the heart: an emerging ally. Cardiol Rev Suppl. November 2000:1-5.
9. Metra M. First large scale double blind study to report on head to head comparison of beta blockers in heart failure. Circulation. 2000;102:546-551.
10. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975;37:1022-1036.
11. Gazes PC. Treatment of congestive heart failure. Med Times. 1982;110(7):31-39.
12. Futterman LG, Lemberg L. Management of congestive heart failure: Is the role of positive inotropic therapy fading? Am J Crit Care. 1996;5:455-460.
13. Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation. 2000;102:IV14-IV23.
14. Bristow M. Enhancing contractile function pharmacologically may improve natural history of heart failure. Cardiol Rev Suppl. November 2000; 17:1-3.
15. Cooper HA. The relationship between diuretics and arrhythmic death in patients with congestive heart failure. Cardiovasc Rev Repts. 2000;21:652-654.
16. Editorial Advisory Board. Heart failure: impact and evolving concepts. Curr Issues Heart Failure. 1999;1:1-12.
17. Klapholz M. Emerging therapies in heart failure. Cardiol Special Ed. 2001;7:71-74.
18. Lemberg L. Digitalis in congestive heart failure: fact or fancy. Arch Intern Med. 1978;138:451-452.
19. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.
20. Rittenhouse SK. Spironolactone for heart failure: a worthy addition to therapy. Advance. January 2001:35-40.